No abstract

Summary Various agents may either enhance or impair post‐prandial gall‐bladder motility, and they are identified in this review. When studying the impact of medication on gall‐bladder motility, the effects on interdigestive gall‐bladder and intestinal motility should also be taken into account. Patients at high risk of gallstone disease, and patients who are treated chronically with gall‐bladder motility inhibiting drugs, may benefit from improved gall‐bladder motility using a prokinetic agent. However, there are no long‐term studies to prove that such a strategy prevents gallstone formation.

No abstract

No abstract